Close

Nymox Pharma (NYMX) Announces Major Fexapotide Development Progress

August 11, 2016 10:30 AM EDT Send to a Friend
Nymox Pharmaceutical Corporation (Nasdaq: NYMX) announces major progress in the evidence for the safety and efficacy of fexapotide, the Company's ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login